🚀 go-pugleaf

Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (March 16, 2013) – Revue de presse (16 mars 2013)


Inadequate Treatment of Ovarian Cancer
A new study has found widespread failure among doctors to follow
clinical guidelines for treating ovarian cancer, which kills 15,000
women a year in this country. This disturbing news shows the kind of
challenge that health care reformers are up against in improving
medical care — even when cost is not the issue.
In The New York Times
http://www.nytimes.com/2013/03/14/opinion/inadequate-treatment-of-ovarian-cancer.html?_r=0

News Blood test tracks cancer
A blood test for DNA shed by dying tumour cells might one day be used
to track a patient's response to therapy, results from a pilot study
in breast cancer suggest. The technique would provide an alternative
to invasive biopsies that retrieve tumour tissue for analysis.
By Heidi Ledford. In Nature
http://www.nature.com/news/blood-test-tracks-cancer-1.12598

FDA approves imaging drug for cancer lymph nodes
The Food and Drug Administration has approved a new imaging drug to
help doctors locate lymph nodes in patients with breast cancer and
skin cancer.
In USA Today
http://www.usatoday.com/story/news/nation/2013/03/13/imaging-drug-cancer/1984857/

Cancer costs
Educating patients is key, but the US National Cancer Institute must
keep spending in check.
In Nature
http://www.nature.com/news/cancer-costs-1.12581

New Monoclonal Antibody Developed That Can Target Proteins Inside
Cancer Cells
Researchers have discovered a unique monoclonal antibody that can
effectively reach inside a cancer cell, a key goal for these important
anticancer agents, since most proteins that cause cancer or are
associated with cancer are buried inside cancer cells. Scientists from
Memorial Sloan-Kettering Cancer Center and Eureka Therapeutics have
collaborated to create the new human monoclonal antibody, which
targets a protein associated with many types of cancer and is of great
interest to cancer researchers.
In Science Daily
http://www.sciencedaily.com/releases/2013/03/130313160757.htm

Blood test reveals women's response to breast cancer treatment
Breast tumour DNA circulating in the bloodstream could be used to
measure how well a woman’s cancer is responding to treatment,
according to a new Cancer Research UK study published in the New
England Journal of Medicine.
In Cancer Research UK
http://www.cancerresearchuk.org/cancer-info/news/archive/pressrelease/2013-03-13-blood-test-reveals-breast-cancer-response

Heart disease risk after breast cancer radiotherapy smaller than
previously thought
Researchers have for the first time calculated by how much
radiotherapy for breast cancer increases the risk of heart disease and
the findings can now be used by doctors to help treat patients more
appropriately, according to a study published in the New England
Journal of Medicine today (Wednesday).
In Cancer Research UK
http://www.cancerresearchuk.org/cancer-info/news/archive/pressrelease/2013-03-13-heart-disease-radiotherapy-breast-cancer



En vidéo : comment faire pour éradiquer le cancer ?
Alors que le cancer a tué près de 150.000 Français en 2011, comment
s’organiser pour faire encore reculer la mortalité de cette terrible
maladie ? Futura-Sciences vous propose deux vidéos qui expliquent
comment, jour après jour, la recherche progresse et s’équipe de
nouvelles armes pour améliorer les soins et les traitements pour les
patients.
Par Janlou Chaput. Dans Futura Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/en-video-comment-faire-pour-eradiquer-le-cancer_45163/

La recherche sur le cancer, toujours une bonne affaire?
La médecine du cancer devrait devenir, selon des prévisions, le
secteur industriel le plus lucratif de la santé au cours des
prochaines années. Un secteur dominé par les géants pharmaceutiques
suisses Roche et Novartis.
Par Chantal Britt. Dans SwissInfo.ch
http://www.swissinfo.ch/fre/economie/La_recherche_sur_le_cancer,_toujours_une_bonne_affaire.html?cid=35214306&link=tdj

Prévenir le cancer et protéger les futures générations de femmes !
Chaque année en France, 1 000 femmes décèdent d'un cancer du col de
l'utérus. Dans le monde, elles sont 275 000, c'est une femme qui meurt
toutes les deux minutes, en majorité dans les pays en développement .
Des cancers et des décès qui peuvent quasiment tous, être évités.
Par Seth Berkley et Jacqueline Godet. Dans Le Monde
http://www.lemonde.fr/idees/article/2013/03/08/prevenir-le-cancer-et-proteger-les-futures-generations-de-femmes_1845051_3232.html

Une piste génétique pour traiter le cancer colorectal
Une équipe anglaise a identifié trois gènes impliqués dans
l'apparition de 60% des cancers colorectaux.
Par Aude Rambaud. Dans Le Figaro santé
http://sante.lefigaro.fr/actualite/2013/03/08/20010-piste-genetique-pour-traiter-cancer-colorectal











Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com













Marc Lacroix-Corman – InTextoResearch – Baelen  (03/2013)